TECLens

United States
Troy, New Hampshire, United States, 10016

Company profile

TECLens company profile

TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, and more.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
10016
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$19.9M
Last funding
Series A / $9.3M / 2025-02-11
Last equity funding
Series A / $9.3M
Investors
4
Lead investors
2
Founders
2
Articles
5

Founders and investors

Founders

David AckerPatrick Lopath

Lead investors

Johnson & Johnson InnovationYonjin Venture

Investors

Johnson & Johnson InnovationRimonci CapitalSunmed CapitalYonjin Venture